-
L’Shana Tovah
Thursday is Rosh Hashahah, the Jewish New Year — 5771 for those keeping count — so we will not have any items posted tomorrow
-
Consortium to Develop Tissue Sample Platform
Bioinformatics provider CLC bio in Aarhus, Denmark, with AROS Applied Biotechnology, F. Hoffmann-La Roche, and the Institute of Pathology at Aarhus University Hospital, announced a collaboration to develop a solution for large scale use of formalin fixed, paraffin embedded (FFPE) tissue in molecular analyses. FFPE tissue samples are invaluable resources for profiling gene expression and…
-
State Grant Awarded for Solar Energy Storage R&D
SunPower Corp. in San Jose, California has received a $1.8 million grant from the California Public Utilities Commission to research photovoltaic (PV) energy storage for large commercial applications. The grant, awarded from the the California Solar Initiative Research, Development, Deployment and Demonstration program, will establish a pilot program to demonstrate the integration of energy storage…
-
EU Approves New Rules for Lab Animals
Rules governing the use of animals in scientific experiments are the product of new EU legislation approved today by the European Parliament. The legislation aims for a better balance between animal welfare and the need for research into diseases. EU member states will have two years to comply with new rules that aim to scale…
-
Genomic Map Developed for Domesticated Turkey
Researchers from the U.S. Department of Agriculture (USDA) and colleagues from universities, research institutes, industry, and other agencies have sequenced the majority of the genome of Meleagris gallopavo, the domesticated turkey, creating the first-ever turkey genome map. The nearly complete map could help growers to more efficiently produce bigger, meatier turkeys. The research is reported…
-
European Patent Awarded for Herpes Treatment
BioAlliance Pharma SA in Paris, France say it has been granted a European patent protecting its product acyclovir Lauriad. This patent, says the company, specifically protects the muco-adhesive tablet containing acyclovir, its process for manufacturing, and its clinical application. According to BioAlliance Pharma, acyclovir Lauriad provides treatment of recurrent herpes labialis with one tablet application…
-
Funding Announced for Carbon Capture and Storage R&D Projects
The U.S. Department of Energy announced the selection of 22 research and development projects on carbon capture and storage (CCS) for industrial sources. Funded with more than $575 million from the American Recovery and Reinvestment Act, these “clean coal” R&D projects follow on earlier industrial demonstration projects also funded through the Recovery Act. Some $312…
-
BP Offers $10 Million to NIH for Gulf Health Research
The oil producer BP said today it is providing $10 million to the National Institutes of Health (NIH) under its Gulf of Mexico Research Initiative (GRI) to support a study of potential public health issues relating to the Gulf oil spill and other spill-related health research. The GRI is a 10-year, $500 million independent research…
-
Phase 2 Clinical Trial Planned for Depression Drug
Rexahn Pharmaceuticals Inc., a clinical stage pharmaceutical company in Rockville, Maryland, submitted today a Phase 2b protocol to the U.S. Food and Drug Administration for the clinical study of Serdaxin, a drug that treats major depressive disorder. The company says Serdaxin may work as an enhancer of serotonin and dopamine in the brain. In Rexahn’s…
-
Forensic Science Center Creates For-Profit Company
The National Forensic Science Technology Center (NFSTC) in Largo, Florida has created the Forensic Innovation Center, a new, for-profit enterprise also in Largo. NFSTC conducts forensic research, education programs, and laboratory quality reviews, and evaluates forensic technologies. The Forensic Innovation Center (FIC) will conduct its work under contracts, separate from the grants and cooperative agreements…